These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dynamic modelling of costs and health consequences of school closure during an influenza pandemic. Xue Y; Kristiansen IS; de Blasio BF BMC Public Health; 2012 Nov; 12():962. PubMed ID: 23140513 [TBL] [Abstract][Full Text] [Related]
7. Simulating school closure policies for cost effective pandemic decision making. Araz OM; Damien P; Paltiel DA; Burke S; van de Geijn B; Galvani A; Meyers LA BMC Public Health; 2012 Jun; 12():449. PubMed ID: 22713694 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the effectiveness of interventions used during the 2009 A/H1N1 influenza pandemic. Halder N; Kelso JK; Milne GJ BMC Public Health; 2010 Mar; 10():168. PubMed ID: 20346187 [TBL] [Abstract][Full Text] [Related]
9. Developing guidelines for school closure interventions to be used during a future influenza pandemic. Halder N; Kelso JK; Milne GJ BMC Infect Dis; 2010 Jul; 10():221. PubMed ID: 20659348 [TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis. Lugnér AK; van Boven M; de Vries R; Postma MJ; Wallinga J BMJ; 2012 Jul; 345():e4445. PubMed ID: 22791791 [TBL] [Abstract][Full Text] [Related]
11. Value for Money in H1N1 Influenza: A Systematic Review of the Cost-Effectiveness of Pandemic Interventions. Pasquini-Descomps H; Brender N; Maradan D Value Health; 2017 Jun; 20(6):819-827. PubMed ID: 28577700 [TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of preemptive school closures to mitigate pandemic influenza outbreaks of differing severity in the United States. Dauelsberg LR; Maskery B; Joo H; Germann TC; Del Valle SY; Uzicanin A BMC Public Health; 2024 Jan; 24(1):200. PubMed ID: 38233845 [TBL] [Abstract][Full Text] [Related]
13. Antiviral treatment for outpatient use during an influenza pandemic: a decision tree model of outcomes averted and cost-effectiveness. Venkatesan S; Carias C; Biggerstaff M; Campbell AP; Nguyen-Van-Tam JS; Kahn E; Myles PR; Meltzer MI J Public Health (Oxf); 2019 Jun; 41(2):379-390. PubMed ID: 29955851 [TBL] [Abstract][Full Text] [Related]
14. Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States. Perlroth DJ; Glass RJ; Davey VJ; Cannon D; Garber AM; Owens DK Clin Infect Dis; 2010 Jan; 50(2):165-74. PubMed ID: 20021259 [TBL] [Abstract][Full Text] [Related]
15. Antiviral medications for pregnant women for pandemic and seasonal influenza: an economic computer model. Lee BY; Bailey RR; Wiringa AE; Assi TM; Beigi RH Obstet Gynecol; 2009 Nov; 114(5):971-980. PubMed ID: 20168096 [TBL] [Abstract][Full Text] [Related]
16. The impact of case diagnosis coverage and diagnosis delays on the effectiveness of antiviral strategies in mitigating pandemic influenza A/H1N1 2009. Kelso JK; Halder N; Milne GJ PLoS One; 2010 Nov; 5(11):e13797. PubMed ID: 21072188 [TBL] [Abstract][Full Text] [Related]
17. Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy. Rothberg MB; Bellantonio S; Rose DN Ann Intern Med; 2003 Sep; 139(5 Pt 1):321-9. PubMed ID: 12965940 [TBL] [Abstract][Full Text] [Related]
18. Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics. Wu DBC; Chaiyakunapruk N; Pratoomsoot C; Lee KKC; Chong HY; Nelson RE; Smith PF; Kirkpatrick CM; Kamal MA; Nieforth K; Dall G; Toovey S; Kong DCM; Kamauu A; Rayner CR Epidemiol Infect; 2018 Mar; 146(4):496-507. PubMed ID: 29446343 [TBL] [Abstract][Full Text] [Related]
19. Economic analysis of the use of facemasks during pandemic (H1N1) 2009. Tracht SM; Del Valle SY; Edwards BK J Theor Biol; 2012 May; 300():161-72. PubMed ID: 22300798 [TBL] [Abstract][Full Text] [Related]